Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Oligodendrocytes and the early multiple sclerosis lesion.
Fatigue in multiple sclerosis - A brief review.
VLA-4 blockade promotes differential routes into human CNS involving PSGL-1 rolling of T cells and MCAM-adhesion of TH17 cells.
Modulation of IL-2Rα with daclizumab for treatment of multiple sclerosis.
Effects of Panax ginseng in Neurodegenerative Diseases.
High risk of MS in Iranian immigrants in Gothenburg, Sweden.
Multiple sclerosis remission following antiretroviral therapy in an HIV-infected man.
Fulminant Central Nervous System Nocardiosis in a Patient Treated With Alemtuzumab For Relapsing-Remitting Multiple Sclerosis.
Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation.
Anti-phospholipid antibodies are associated with response to interferon-beta1a treatment in MS: results from a 3-year longitudinal study.
Treatment of multiple sclerosis with cyclophosphamide: critical review of clinical and immunologic effects.
A major histocompatibility Class I locus contributes to multiple sclerosis susceptibility independently from HLA-DRB1*15:01.
Accelerated and enhanced effect of CCR5-transduced bone marrow neural stem cells on autoimmune encephalomyelitis.
Improved ability to work after one year of natalizumab treatment in multiple sclerosis. Analysis of disease-specific and work-related factors that influence the effect of treatment.
PEGylated interferon beta-1a in the treatment of multiple sclerosis - an update.
Evaluation of oxidative and nitrosative stress in relapsing remitting multiple sclerosis: effect of corticosteroid therapy.
Early activation of CD4+ and CD8+ T lymphocytes by myelin basic protein in subjects with MS.
Two Years Follow up of Domain Specific Cognitive Training in Relapsing Remitting Multiple Sclerosis: A Randomized Clinical Trial.
In vitro Biological Characterization of IFN-β-1a major Glycoforms.
Benefit of additional screening for progressive multifocal leukoencephalopathy in patients with multiple sclerosis taking natalizumab: a decision analysis.
Cost-effectiveness of natalizumab vs fingolimod for the treatment of relapsing-remitting multiple sclerosis: analyses in Sweden.
Exercise and quality of life in women with multiple sclerosis.
Predicted structure of MIF/CD74 and RTL1000/CD74 complexes.
Alemtuzumab (Lemtrada) - NICE says yes in final draft guidance
Improving Hand Functional Use in Subjects with Multiple Sclerosis Using a Musical Keyboard: A Randomized Controlled Trial.

Pages